Skip to Content

Apidra Aventis Pharmaceuticals Inc. - Treatment for Diabetes Mellitus

Apidra is a recombinant DNA human insulin analogue that has a more rapid onset and a shorter duration of action than regular human insulin. Apidra is used for the control of hyperglycemia in adult patients with diabetes mellitus.

Related Articles:

Apidra (insulin glulisine) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.